rare disease data center
Accelerate Rare Disease Data Center vs ARC Investor Edge
Accelerate Rare Disease Data Center vs ARC Investor Edge The Rare Disease Data Center accelerates early-stage pipeline work by cutting diagnosis time by about 23%, while the ARC Investor Edge program adds a further 40% boost to pipeline throughput, together delivering faster orphan-drug development. Investors see these gains as a